Addex Therapeutics Ltd(ADXN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADXN Addex Therapeutics Ltd

Post-Mkt 02-11 16:15:37 EST

7.72

-0.03

-0.39%

盘后7.61

-0.11-1.42%

16:00 EST

High7.89	Low7.40	Vol2.18K
Open7.89	D1 Closing7.75	Amplitude6.32%
Mkt Cap9.51M	Tradable Cap8.04M	Total Shares1.23M
T/O16.79K	T/O Rate0.21%	Tradable Shares1.04M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADXN","market":"US","secType":"STK","nameCN":"Addex Therapeutics Ltd","latestPrice":7.72,"timestamp":1770843600000,"preClose":7.75,"halted":0,"volume":2177,"hourTrading":{"tag":"盘后","latestPrice":7.61,"preClose":7.72,"latestTime":"16:00 EST","volume":20,"amount":152.20000000000002,"timestamp":1770843601059,"change":-0.11,"changeRate":-0.014249,"amplitude":0},"delay":0,"changeRate":-0.003870967741935516,"floatShares":1041800,"shares":1232000,"eps":-8.952971,"marketStatus":"Post-Mkt","change":-0.03,"latestTime":"02-11 16:15:37 EST","open":7.89,"high":7.89,"low":7.4,"amount":16785.1018,"amplitude":0.063226,"askPrice":8.56,"askSize":100,"bidPrice":3.06,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-8.952971,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770858000000},"marketStatusCode":4,"adr":0,"adrRate":120,"exchange":"NASDAQ","adjPreClose":7.75,"postHourTrading":{"tag":"盘后","latestPrice":7.61,"preClose":7.72,"latestTime":"16:00 EST","volume":20,"amount":152.20000000000002,"timestamp":1770843601059,"change":-0.11,"changeRate":-0.014249,"amplitude":0},"volumeRatio":0.622356},"requestUrl":"/m/hq/s/ADXN/wiki","defaultTab":"wiki","newsList":[{"id":"2608082273","title":"Addex publishes negative allosteric modulators data in Molecular Psychiatry","url":"https://stock-news.laohu8.com/highlight/detail?id=2608082273","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608082273?lang=en_us&edition=fundamental","pubTime":"2026-02-03 18:40","pubTimestamp":1770115243,"startTime":"0","endTime":"0","summary":"Addex Therapeutics (ADXN) announced publication of data in Molecular Psychiatry demonstrating that targeting metabotropic glutamate receptor 7 with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/addex-publishes-negative-allosteric-modulators-data-in-molecular-psychiatry-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/addex-publishes-negative-allosteric-modulators-data-in-molecular-psychiatry-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ADXN","BK4007"],"gpt_icon":0},{"id":"2608841259","title":"Press Release: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2608841259","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608841259?lang=en_us&edition=fundamental","pubTime":"2026-02-03 14:00","pubTimestamp":1770098400,"startTime":"0","endTime":"0","summary":"Geneva, Switzerland, February 3, 2026 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today publication of data in Molecular Psychiatry demonstrating that targeting metabotropic glutamate receptor 7  with negative allosteric modulators  could be transformative in the treatment of anxiety and fear-related disorders, such as post-traumatic stress disorder .In the study, scientists from the Center for Psychiatric Neurosciences  in Lausanne, Switzerland, evaluated the effects of ADX71743, a highly selective mGlu7 NAM, in established models of fear learning and memory. The results demonstrated that mGlu7 modulation can selectively interfere with the reconsolidation of fear memories, the process in the brain that re-stabilizes a fear memory after it is recalled. This process is increasingly being recognized as a potential therapeutic intervention point in an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADXN","BK4139","BK4007"],"gpt_icon":0},{"id":"2603631939","title":"Addex Therapeutics Ltd – ADR trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2603631939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603631939?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:31","pubTimestamp":1768325478,"startTime":"0","endTime":"0","summary":"12:25 EST Addex Therapeutics (ADXN) Ltd – ADR trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/addex-therapeutics-ltd-adr-trading-resumes-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/addex-therapeutics-ltd-adr-trading-resumes-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADXN","BK4139","BK4007"],"gpt_icon":0},{"id":"2603639284","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:15 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2603639284","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603639284?lang=en_us&edition=fundamental","pubTime":"2026-01-14 01:15","pubTimestamp":1768324514,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:15 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nAQN2LHI6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADXN","BK4007","BK4139"],"gpt_icon":0},{"id":"2584975296","title":"Addex Therapeutics files to sell $150M in ordinary shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584975296","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584975296?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:05","pubTimestamp":1763586343,"startTime":"0","endTime":"0","summary":"16:02 EST Addex Therapeutics (ADXN) files to sell $150M in ordinary shares Published first on TheFly – the ultimate source for real-time, market-mo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/addex-therapeutics-files-to-sell-150m-in-ordinary-shares-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/addex-therapeutics-files-to-sell-150m-in-ordinary-shares-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADXN","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2576061348","title":"ADRs Hold Steady; Addex Therapeutics Ltd. Climbs 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576061348","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576061348?lang=en_us&edition=fundamental","pubTime":"2025-10-18 04:30","pubTimestamp":1760733000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed flat on Friday, as the S&P/BNY Mellon index of American depositary receipts was flat at 227.79.The European index added 0.3% to 198.73. The Asian index fell 0.2% to 309.91. The Latin American index rose 0.5% to 214.48, while the emerging-markets index fell 0.4% to 518.77.Switzerland's Addex Therapeutics Ltd. was the biggest leader during the session, rocketing 28% to $10.95, and Japan-based LEIFRAS Co. Ltd. soared 24% to $4.20. XCHG Ltd., which is based in China, rounded out the top three leaders on Friday, with shares jumping 16% to $1.76.Evaxion A/S, based in Denmark, posted the largest decline, plummeting 29% to $6.79, followed by shares of China's Lixiang Education Holding Co. Ltd., which plunged 18% to 32 cents. Shares of China-based 9F Inc. tumbled 16% to $3.75.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ADXN"],"gpt_icon":0},{"id":"2571933397","title":"Press Release: Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2571933397","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571933397?lang=en_us&edition=fundamental","pubTime":"2025-09-30 13:00","pubTimestamp":1759208400,"startTime":"0","endTime":"0","summary":"-- Cash position of CHF 2.3 million at end of H1 2025. -- GABAB PAM chronic cough candidate demonstrated robust anti-tussive. -- Regained rights to phase 2 mGlu2 PAM asset, ADX71149. -- Indivior advanced GABAB PAM substance use disorders program successfully. -- Entered option agreement with Sinntaxis for exclusive license to. intellectual property covering the use of mGlu5 NAM in brain injury. -- Invested in Stalicla SA, confirming commitment to advancing innovative. Geneva, Switzerland, September 30, 2025 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its half-year and second quarter financial results for the periods ended June 30, 2025, and provided a corporate update.-- Indivior advanced its GABAB PAM program for substance use disorders. intellectual property covering use of mGlu5 NAM in brain injury recovery. -- Invested in Stalicla, continu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ADXN","BK4007","LENZ"],"gpt_icon":0},{"id":"2568414701","title":"ADRs Advance; Addex Therapeutics Ltd. Climbs 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568414701","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568414701?lang=en_us&edition=fundamental","pubTime":"2025-09-18 04:30","pubTimestamp":1758141000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Wednesday, as the S&P/BNY Mellon index of American depositary receipts gained 0.6% to 222.48.The European index added 0.2% to 193.78. The Asian index gained 1.0% to 302.85. The Latin American index rose 0.4% to 215.89, while the emerging-markets index gained 1.1% to 498.27.Switzerland's Addex Therapeutics Ltd. was the biggest leader during the session, jumping 16% to $10.85, and China-based 17 Education & Technology Group Inc. surged 15% to $3.55. Valneva SE, which is based in France, rounded out the top three leaders on Wednesday, with shares jumping 12% to $9.97.Huize Holding Ltd., based in China, posted the largest decline, cratering 21% to $3.06, followed by shares of China's MOGU Inc., which tumbled 16% to $4.20. Shares of Israel-based Steakholder Foods Ltd. plunged 11% to $4.89.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADXN","BK4139","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.addextherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":-0.0064},{"period":"3month","weight":-0.1203},{"period":"6month","weight":0.0306},{"period":"1year","weight":0.0544},{"period":"ytd","weight":0.0039}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.20245},{"month":2,"riseRate":0.428571,"avgChangeRate":0.100621},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.133714},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084878},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.045376},{"month":6,"riseRate":0.5,"avgChangeRate":-0.090557},{"month":7,"riseRate":0.666667,"avgChangeRate":0.007044},{"month":8,"riseRate":0.333333,"avgChangeRate":0.10966},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.0989},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.063794},{"month":11,"riseRate":0,"avgChangeRate":-0.116863},{"month":12,"riseRate":0.5,"avgChangeRate":-0.002424}],"exchange":"NASDAQ","name":"Addex Therapeutics Ltd","nameEN":"Addex Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Addex Therapeutics Ltd(ADXN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Addex Therapeutics Ltd(ADXN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Addex Therapeutics Ltd,ADXN,Addex Therapeutics Ltd股票,Addex Therapeutics Ltd股票老虎,Addex Therapeutics Ltd股票老虎国际,Addex Therapeutics Ltd行情,Addex Therapeutics Ltd股票行情,Addex Therapeutics Ltd股价,Addex Therapeutics Ltd股市,Addex Therapeutics Ltd股票价格,Addex Therapeutics Ltd股票交易,Addex Therapeutics Ltd股票购买,Addex Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Addex Therapeutics Ltd(ADXN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Addex Therapeutics Ltd(ADXN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}